|Institutional Source||Beutler Lab|
|Gene Name||mediator complex subunit 17|
|Synonyms||Trap80, C330002H14Rik, Crsp6|
|Is this an essential gene?||Probably essential (E-score: 0.966)|
|Stock #||R2912 (G1)|
|Chromosomal Location||15260351-15279931 bp(-) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||A to G at 15275914 bp|
|Amino Acid Change||Leucine to Proline at position 188 (L188P)|
|Ref Sequence||ENSEMBL: ENSMUSP00000034411 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000034411] [ENSMUST00000216406]|
|Predicted Effect||probably damaging
AA Change: L188P
PolyPhen 2 Score 1.000 (Sensitivity: 0.00; Specificity: 1.00)
AA Change: L188P
|Predicted Effect||noncoding transcript
|Predicted Effect||probably benign
|Coding Region Coverage||
|MGI Phenotype||FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. [provided by RefSeq, Jul 2008]|
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Med17||
(F):5'- AATGGTTTGGGCTTACAGGTAAAG -3'
(R):5'- GCCTCATGCTTGCATGGTAC -3'
(F):5'- GATCTGTACCTGCACTTC -3'
(R):5'- TGGTACACCCCTTGCCAG -3'